this appointment seem specifically for the XV scanner and not necessarily for the software XV LVAS broader commercialisation eg. VA PACT etc... this is how I read it.... and I am surprised given this scanner is not FDA or TGA approved, so they must be very confident it will be approved in early 2023 to commence the commercial discussions.
Ann: Appointment of Senior VP Business Development, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $184.7M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 46.5¢ | 44.0¢ | $153.2K | 338.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 42672 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 6067 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |